Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of High Flow Nasal Cannula Oxygen During Acute Hypoxemic Respiratory Failure Related to Covid-19 and Interest of the Respiratory-oxygenation Index (ROX Index): an Observational Study

NCT04385823 is registered in ClinicalTrials.gov with Hôpital Louis Mourier as lead sponsor.

NCT NCT04385823
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04385823 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of High Flow Nasal Cannula Oxygen During Acute Hypoxemic Respiratory Failure Related to Covid-19 and Interest of the Respiratory-oxygenation Index (ROX Index): an Observational Study
Lead sponsor
Hôpital Louis Mourier
Phase
Observational
Overall status
Completed
Start date
March 1, 2020
Completion date
May 4, 2020
Enrollment
62 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypoxic respiratory failure, respiratory syndrome, acute, severe, viral pneumonia